Skip to main content
SpringerLink
Log in

Therapie des lokalisierten nodulären Lymphozyten-prädominanten Hodgkin-Lymphoms bei Kindern

Treatment of low-risk pediatric lymphocyte-predominant Hodgkin lymphoma

  • Literatur kommentiert
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Appel BE, Chen L, Buxton AB et al (2016) Minimal treatment of low-risk, pediatric lymphocyte-predominant Hodgkin Lymphoma: A report from the Children’s Oncology Group. J Clin Oncol 34:2372–2379

    Article  PubMed  Google Scholar 

  2. Arber DA, Orazi A, Hasserjian R (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127:2391–2405

    Article  PubMed  Google Scholar 

  3. Mauz-Körholz C, Gorde-Grosjean S, Hasenclever D et al (2007) Resection alone in 58 children with limited stage, lymphocyte-predominant Hodgkin lymphoma-experience from the European network group on pediatric Hodgkin lymphoma. Cancer 110:179–185

    Article  PubMed  Google Scholar 

  4. Shankar A, Hall GW, Gorde-Grosjean S et al (2012) Treatment outcome after low intensity chemotherapy [CVP] in children and adolescents with early stage nodularlymphocyte predominant Hodgkin’slymphoma – an Anglo-French collaborative report. Eur J Cancer 48:1700–1706

    Article  PubMed  Google Scholar 

  5. Shankar AG, Kirkwood AA, Depani S et al (2016) Relapsed or poorly responsive nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents – a report from the United Kingdom’s Children’s Cancer and Leukaemia Study Group. Br J Haematol 173:421–431

    Article  PubMed  Google Scholar 

  6. Fan Z, Natkunam Y, Bair E et al (2003) Characterization of variant patterns of nodular lymphocyte predominant Hodgkin lymphoma with immunohistologic and clinicalcorrelation. Am J Surg Pathol 27:1346–1356

    Article  PubMed  Google Scholar 

  7. Boudová L, Torlakovic E, Delabie J et al (2003) Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T‑cell/histiocyte-rich B‑cell lymphoma: differential diagnosis between nodular lymphocyte predominant Hodgkin lymphoma and T‑cell/histiocyte-rich B‑cell lymphoma. Blood 102:3753–3758

    Article  PubMed  Google Scholar 

  8. Hartmann S, Eichenauer DA, Plütschow A et al (2013) The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report fromthe German Hodgkin Study Group (GHSG). Blood 122:4246–4252

    Article  CAS  PubMed  Google Scholar 

  9. Schellong G, Pötter R, Brämswig J et al (1999) High cure rates and reduced long-term toxicity in pediatric Hodgkin’s disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin’s Disease Study Group. J Clin Oncol 17:3736–3744

    CAS  PubMed  Google Scholar 

  10. Dörffel W, Rühl U, Lüders H et al (2013) Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95. J Clin Oncol 31:1562–1568

    Article  PubMed  Google Scholar 

  11. Mauz-Körholz C, Hasenclever D, Dörffel W et al (2010) Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin’s lymphoma: the GPOH-HD-2002 study. J Clin Oncol 28:3680–3686

    Article  PubMed  Google Scholar 

  12. Advani RH, Horning SJ, Hoppe RT et al (2014) Mature results of a phase II study of rituximab therapy for nodular lymphocyte-predominant Hodgkin lymphoma. J Clin Oncol 32:912–918

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. St. Anna Kinderkrebsforschung, St. Anna Kinderspital, UKKJ, MUW, Kinderspitalgasse 6, 1090, Wien, Österreich

    Georg Mann &  Wolfgang Holter

Authors
  1. Georg Mann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wolfgang Holter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Georg Mann.

Ethics declarations

Interessenkonflikt

G. Mann und W. Holter geben an, dass kein Interessenkonflikt besteht.

Additional information

Originalpublikation Appel BE, Chen L, Buxton AB et al (2016) Minimal treatment of low-risk, pediatric lymphocyte-predominant Hodgkin lymphoma: a report from the Children’s Oncology Group. J Clin Oncol pii: JCO653469 [1]

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mann, G., Holter, W. Therapie des lokalisierten nodulären Lymphozyten-prädominanten Hodgkin-Lymphoms bei Kindern. Strahlenther Onkol 192, 827–829 (2016). https://doi.org/10.1007/s00066-016-1044-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-016-1044-2

Search

Navigation